5 ml
Sponsors
Centre Hospitalier Universitaire De Saint Etienne, Aalborg University Hospital, Institut Pasteur, Assistance Publique Hopitaux De Marseille, Hopital Fondation Adolphe De Rothschild
Conditions
Bacterial vaginosisBrain abscessCOVID-19 and fluCrohn’s DiseaseHigh risk preterm birth pregnancyHurley stage 2 active Hidradenitis SuppurativaHyperkalemiaIschemic stroke
Phase 2
Evaluation of the efficacy of intra venous dornase alfa (Pulmozyme®) on arterial recanalization in post-thrombectomy angiography in patients managed for ischemic stroke with thrombolysis and eligible for thrombectomy: a single-center phase II trial.
CompletedCTIS2024-515831-31-00
Start: 2022-08-19End: 2025-10-29Target: 44Updated: 2024-10-22
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), PROGRESSIVE AFTER GEMCITABINE-ABRAXANE OR GEMCITABINE MONOTHERAPY.
RecruitingCTIS2024-516336-97-00
Start: 2022-02-21Target: 134Updated: 2025-02-25
CONCOMITANT ADMINISTRATION OF LICENSED VACCINES AGAINST COVID-19 AND FLU WITH OR WITHOUT MF59 ADJUVANT: A MULTI-CENTRE, RANDOMIZED, SINGLE-BLIND CLINICAL TRIAL TO ASSESS IMMUNOGENICITY IN ADULTS AGED 65 AND OVER
CompletedCTIS2024-514798-23-00
Start: 2024-10-02End: 2025-03-04Target: 120Updated: 2024-10-14
Efficacy of daily IV administration of dornase alfa for up to 14 days post subarachnoid haemorrhage on functional independence at 6 months: a multicentre open-label randomised controlled trial of the PROBE type Probe
Not yet recruitingCTIS2023-509627-40-01
Target: 314Updated: 2025-09-24
Reduction of SystemiC Inflammation after ischemic stroke by intravenous DNase administration (ReSCInD)
Not yet recruitingCTIS2024-516701-22-00
Target: 36Updated: 2025-06-04
Phase 3
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE
RecruitingCTIS2022-500974-33-00
Start: 2023-08-12Target: 1400Updated: 2025-04-25
A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients versus Tetracycline Derivative (ABCESS2)
RecruitingCTIS2023-505818-16-00
Start: 2025-05-22Target: 92Updated: 2026-01-15
TRAUMADORNASE
A Prospective, Randomized Multicenter, Double Blind Clinical Trial Comparing
Inhaled Dornase Alfa and Its Placebo to Reduce the Incidence of Moderate to
Severe ARDS in Ventilated Trauma Patients in the Intensive Care Unit
RecruitingCTIS2024-512034-14-00
Start: 2019-03-04Target: 500Updated: 2025-01-20
Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial
Not yet recruitingCTIS2024-514633-38-00
Target: 166Updated: 2025-10-15
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of the Global Ballad pooled data analysis.
Not yet recruitingCTIS2024-518349-85-01
Target: 30Updated: 2024-11-20
ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoing intra-vesical botulinum toxin A injections
Not yet recruitingCTIS2024-515107-19-00
Target: 526Updated: 2025-11-10
AUTOP 2 : Screen-and-treat strategy for vaginal flora abnormalities by molecular biology in pregnant women at high risk of preterm birth: A Multicentre, Randomized Study
Not yet recruitingCTIS2023-509421-41-03
Target: 1794Updated: 2026-04-01
Phase 4
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL)
RecruitingCTIS2023-505483-11-00
Start: 2021-05-02Target: 370Updated: 2025-02-27
InSaKa trial: Insulin dextrose infusion versus nebulized salbutamol versus combination of salbutamol and insulin dextrose in acute hyperkalemia: a randomized clinical trial
CompletedCTIS2024-514889-40-00
Start: 2019-12-20End: 2025-12-20Target: 525Updated: 2024-07-19
Efficacy of botulinum toxin vs corticosteroid in the management of persistent post-surgical scar pain
Not yet recruitingCTIS2024-518954-18-01
Target: 60Updated: 2024-12-05